脑部放疗，上午比下午敏感许多！/ v' c3 ~9 }1 h, O( a
6 } P1 R/ q }; o9 ?) A$ I
) J/ y- N# _4 c3 h* ^" C! {1 D5 p. |
Cancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9. l! A8 u1 w1 z( N
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?
3 }. |) k/ w1 zRahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.5 d# S' `3 [9 |: u( K# J+ e" o
SourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.0 j# N! V% v u) Z1 C
( H" }4 o6 w9 }8 ~5 I
Abstract. D$ c1 D* @7 A" W5 G4 x2 V0 b# f9 e
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.- k7 p% t; R% A) f# W! @1 p2 x
( d% ?0 ~) @7 B. D: p% b
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
- B7 E: B+ P( T! _+ r: T! I* S. S2 c
RESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026). w8 B' k' y: c* h0 }' Q$ d' Z
: M: d( Z4 p2 ^CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
/ w+ ^7 J" u2 R: N
$ F0 @! w$ u$ N8 R( I: j6 | |
显身卡
